Yahoo Finance • 24 days ago
(RTTNews) - The biotech industry witnessed several key events this week, including major FDA approvals, acquisitions, pivotal clinical trial results and setbacks. • A series of FDA approvals were announced during the week, with GSK, Haloz... Full story
Yahoo Finance • 27 days ago
Check out the companies making the biggest moves in midday trading: Texas Pacific Land — Shares of the large Texas landowner jumped 8% after it struck a deal with Bolt Data & Energy to develop large-scale data center campuses on properties... Full story
Yahoo Finance • 27 days ago
European equities traded in the US as American depositary receipts were trending modestly higher lat PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 27 days ago
US stock futures are tracking higher in Wednesday's premarket session as investors dissect Tuesday's PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 29 days ago
European equities traded in the US as American depositary receipts kicked off the week higher late M PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 29 days ago
Chaay_Tee / iStock via Getty Images Quick Read Stocks were hit hard on Friday as the rotation out of the Artificial Intelligence trade continued. Many on Wall Street remain leery of the huge debt being piled up by technology companies. O... Full story
Yahoo Finance • last month
Thinkstock Quick Read After a brutal Monday, investors were treated to a snap-back rally in stocks on Tuesday. All of the major indices and Cryptocurrencies finished the day higher on Tuesday as hopes for an interest rate cut remained po... Full story
Yahoo Finance • 2 months ago
Châtillon, France, November 4, 2025 DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a cli... Full story
Yahoo Finance • 2 months ago
Châtillon, France, le 4 novembre (22 :30 CET) 2025 DBV Technologies participera à la 2e conférence annuelle Guggenheim Healthcare Innovation DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT— CUSIP : 233... Full story
Yahoo Finance • 2 months ago
Châtillon, France, October 30, 2025 DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “DBV”), a clinical-stag... Full story
Yahoo Finance • 2 months ago
Châtillon, France, 30 octobre 2025 DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein de son Conseil d’administration DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (la « Société » ou « DBV... Full story
Yahoo Finance • 2 months ago
Châtillon, France, October 29, 2025 DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT... Full story
Yahoo Finance • 2 months ago
Châtillon, France, 29 octobre 2025 DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (la « Société » ou « DBV... Full story
Yahoo Finance • 3 months ago
Châtillon, France, October 28, 2025 DBV Technologies Reports Third Quarter 2025 Financial Results DBV closes Q3 2025 with a cash and cash equivalents balance of $69.8 million, taking cash runway into the third quarter of 2026 DBV Techno... Full story
Yahoo Finance • 3 months ago
Châtillon, France, 28 octobre 2025 DBV Technologies publie ses résultats financiers du troisième trimestre 2025 DBV clôture le troisième trimestre 2025 avec un solde de trésorerie & équivalents de trésorerie de 69,8 millions de dollars p... Full story
Yahoo Finance • 4 months ago
Châtillon, France, September 18, 2025 DBV Technologies Announces Resignation of Board Member DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “DBV”), a clinical-stage biopharmaceutical compan... Full story
Yahoo Finance • 4 months ago
Châtillon, France, le 18 septembre 2025 DBV Technologies annonce la démission d’un membre de son Conseil d’administration DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (la “Société” ou “DBV”), une société b... Full story
Yahoo Finance • 4 months ago
* DBV Technologies (NASDAQ:DBVT [https://seekingalpha.com/symbol/DBVT]) filed a prospectus supplement with the SEC for an at-the-market offering up to $150M of American Depositary Shares. * Each ADS represents five ordinary shares of t... Full story
Yahoo Finance • 4 months ago
Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a clinical-stage biopharmaceu... Full story
Yahoo Finance • 4 months ago
Châtillon, France, le 5 septembre (22:30 CEST) 2025 DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Capital Market : DBVT) (la « Société »), une... Full story